Legalization of Recreational Cannabis in Maryland: Health Implications

On June 27, we held a press briefing to discuss the implications of the upcoming legalization of cannabis in Maryland. Renowned experts in the field provided important updates and insights on various aspects of cannabis legalization, emphasizing the need for more research.
Mark Gladwin, MD, Dean, University of Maryland School of Medicine.
Eric Weintraub, MD, Associate Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine and Division Head of Alcohol & Drug Abuse at the University of Maryland Medical Center.
Chad Johnson, PhD, Assistant Professor of Pharmaceutical Sciences and Co-Director of the Graduate Studies in Medical Cannabis Program at the University of Maryland School of Pharmacy.
Daniel Gingold, MD, MPH, Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and emergency physician at the University of Maryland Medical Center.
Asaf Keller, MD, Chair of Neurobiology and Associate Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine.
The University of Maryland School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond.

[@WilmaAlvarado-nz6mz]

Okgracias y saludos

[@tommybombadil8651]

Marijuana is already the most studied plant on Earth, and is arguably one of the most investigated therapeutically active substances known to man.
To date, there are now over 20,000 published studies or reviews in the scientific literature pertaining to marijuana and its active compounds. NORML

[@falconinflight6235]

Government officials and employees on top of Government Positions and employees all living large lifestyles off the taxpayers.